Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 36.22% vs 42.62% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 147.75% vs -46.38% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 26.76% vs -12.68% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 22.82% vs 22.13% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Nath Bio-Genes With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -84.54% vs 445.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 36.22% vs 42.62% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -92.62% vs 2,418.92% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 147.75% vs -46.38% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -84.04% vs 9,239.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 26.76% vs -12.68% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 14.37% vs 133.58% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 22.82% vs 22.13% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






